Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

Axogen, Inc.

AXGN Clue Score44
United States Fiscal year ends December CIK 0000805928 Results filed 28 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Doris Quackenbush
7 May 2026
Sales VP
Sell
3,878
$43.51
$168.72K
Jens Kemp
7 May 2026
Chief Marketing Officer
Sell
4,000
$43.44
$173.76K
Marc A Began
11 Dec 2025
EVP & General Counsel
Sell
13,222
$30.00
$396.66K
Michael D Dale
10 Dec 2025
Chief Executive Officer
Sell
25,000
$30.00
$750.00K
Paul Thomas
9 Dec 2025
Director
Sell
21,399
$29.61
$633.71K
Marc A Began
9 Dec 2025
EVP & General Counsel
Sell
9,278
$31.21
$289.55K
Jens Kemp
9 Dec 2025
Chief Marketing Officer
Sell
8,156
$31.21
$254.53K
Erick Wayne DeVinney
9 Dec 2025
Chief Innovation Officer
Sell
19,517
$31.21
$609.09K
Michael D Dale
9 Dec 2025
Chief Executive Officer
Sell
61,463
$31.21
$1.92M

What was left out

Form 4 filings counted 51
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 25
Sales at will 9
Transactions with no price 0
Shares from compensation/vesting 910,696
History held since 24 Sep 2007